Search results
Found 31107 matches for
New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).
Clinical Kennedy Trust Prize Studentships
Applications for these projects close at noon on Friday 2 December 2025.
Botnar projects
Applications for these projects close at noon on Friday 2 December 2025.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.